Tredje AP-fonden’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.1M | Buy |
+359,230
| New | +$50.3M | 0.27% | 72 |
|
|
2024
Q1 | – | Sell |
-59,687
| Closed | -$4.84M | – | 504 |
|
|
2023
Q4 | $4.84M | Buy |
59,687
+5,270
| +10% | +$410K | 0.06% | 202 |
|
|
2023
Q3 | $4.08M | Hold |
54,417
| – | – | 0.06% | 207 |
|
|
2023
Q2 | $4.19M | Hold |
54,417
| – | – | 0.06% | 222 |
|
|
2023
Q1 | $4.51M | Buy |
54,417
+7,876
| +17% | +$652K | 0.07% | 197 |
|
|
2022
Q4 | $4M | Buy |
46,541
+4,700
| +11% | +$372K | 0.07% | 207 |
|
|
2022
Q3 | $2.58M | Sell |
41,841
-83,683
| -67% | -$5.28M | 0.05% | 279 |
|
|
2022
Q2 | $7.76M | Hold |
125,524
| – | – | 0.2% | 109 |
|
|
2022
Q1 | $7.46M | Hold |
125,524
| – | – | 0.15% | 123 |
|
|
2021
Q4 | $9.11M | Hold |
125,524
| – | – | 0.18% | 114 |
|
|
2021
Q3 | $8.77M | Hold |
125,524
| – | – | 0.18% | 117 |
|
|
2021
Q2 | $8.64M | Hold |
125,524
| – | – | 0.18% | 89 |
|
|
2021
Q1 | $8.11M | Hold |
125,524
| – | – | 0.19% | 97 |
|
|
2020
Q4 | $7.31M | Hold |
125,524
| – | – | 0.19% | 97 |
|
|
2020
Q3 | $7.93M | Hold |
125,524
| – | – | 0.26% | 72 |
|
|
2020
Q2 | $9.66M | Sell |
125,524
-30,000
| -19% | -$2.3M | 0.4% | 60 |
|
|
2020
Q1 | $11.6M | Sell |
155,524
-3,571
| -2% | -$247K | 0.6% | 44 |
|
|
2019
Q4 | $10.3M | Sell |
159,095
-15,745
| -9% | -$1.03M | 0.52% | 44 |
|
|
2019
Q3 | $11.1M | Buy |
174,840
+27,000
| +18% | +$1.76M | 0.53% | 41 |
|
|
2019
Q2 | $9.99M | Buy |
147,840
+1,988
| +1% | +$131K | 0.48% | 48 |
|
|
2019
Q1 | $9.48M | Buy |
145,852
+18,188
| +14% | +$1.21M | 0.49% | 48 |
|
|
2018
Q4 | $7.99M | Sell |
127,664
-43,245
| -25% | -$3.02M | 0.49% | 48 |
|
|
2018
Q3 | $13.2M | Sell |
170,909
-23,417
| -12% | -$1.77M | 0.64% | 36 |
|
|
2018
Q2 | $13.8M | Buy |
194,326
+3,737
| +2% | +$264K | 0.48% | 55 |
|
|
2018
Q1 | $14.4M | Buy |
190,589
+1,265
| +0.7% | +$101K | 0.51% | 43 |
|
|
2017
Q4 | $13.6M | Sell |
189,324
-5,830
| -3% | -$443K | 0.46% | 50 |
|
|
2017
Q3 | $15.8M | Sell |
195,154
-2,622
| -1% | -$200K | 0.56% | 39 |
|
|
2017
Q2 | $14M | Sell |
197,776
-2,639
| -1% | -$176K | 0.52% | 42 |
|
|
2017
Q1 | $13.6M | Sell |
200,415
-1,313
| -0.7% | -$92.3K | 0.54% | 41 |
|
|
2016
Q4 | $14.4M | Sell |
201,728
-502
| -0.2% | -$37.3K | 0.61% | 36 |
|
|
2016
Q3 | $16M | Sell |
202,230
-12,012
| -6% | -$976K | 0.72% | 25 |
|
|
2016
Q2 | $17.9M | Sell |
214,242
-21,070
| -9% | -$1.87M | 0.8% | 26 |
|
|
2016
Q1 | $19.7M | Sell |
235,312
-41,494
| -15% | -$3.74M | 0.9% | 25 |
|
|
2015
Q4 | $28M | Buy |
276,806
+69,393
| +33% | +$7.22M | 1.8% | 6 |
|
|
2015
Q3 | $20.4M | Buy |
207,413
+199,305
| +2,458% | +$22.1M | 1.99% | 7 |
|
|
2015
Q2 | $949K | Buy |
+8,108
| New | +$886K | 0.08% | 267 |
|
Other funds holding GILD
VCM
VPM
Tredje AP-fonden's GILD Position: Q1 2026 in Review
Tredje AP-fonden opened a new position in Gilead Sciences (GILD) in Q1 2026: 359,230 shares worth $50.1M. The stake represents 0.27% of the portfolio and ranks #72 among its holdings. This is a return to the name: Tredje AP-fonden previously reported a position in GILD as recently as Q4 2023.
Tredje AP-fonden first reported a position in GILD in Q2 2015 and has held it in 36 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Tredje AP-fonden held 359,230 shares of Gilead Sciences worth $50.1M as of Q1 2026.
- Gilead Sciences was a new Tredje AP-fonden position in Q1 2026.
- Gilead Sciences made up 0.27% of Tredje AP-fonden's portfolio in Q1 2026, its #72 holding.
- Tredje AP-fonden first reported a position in Gilead Sciences in Q2 2015 and has held it in 36 quarters since.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Tredje AP-fonden's 13F filing for Q1 2026, filed 12 May 2026.